arrow
T

Tomáš Honzík

Charles University and General University Hospital in Prague
H指数:35
被引数:4,958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights Into the Pathological Glycosylation Associated With COG6-CDG

COG6-CDG相关病理糖基化的研究进展

2025-11-300
OAAI
Corrigendum to “Incidence and prevalence of phosphomannomutase 2-congenital disorder of glycosylation: Past, present, and future [Molecular Genetics and Metabolism 146 (2025) 109188]”

勘误:“Phosphomannomutase 2-congenital disorder of glycosylation的发病率和患病率:过去、现在和未来 [Molecular Genetics and Metabolism 146 (2025) 109188]”

2025-10-140
OAAI
A prevalent MOCS2 variant in the Roma population is associated with a novel mild form of molybdenum cofactor deficiency

在罗姆人群中普遍存在的MOCS2变异与一种新型的轻度钼辅因子缺乏症相关。

2025-07-250
OA
A novel cause of type 1 Von Willebrand Disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants

1型血管性血友病的一种新型病因:由于双等位基因MADD变异导致Weibel-Palade小体的外排障碍

Blood
IF23.1
2025-07-170
PREAI
Glycosphingolipid synthesis is impaired in SLC35A2-CDG and improves with galactose supplementation

SLC35A2-CDG中糖鞘脂合成受损,且可通过添加半乳糖得到改善。

2025-06-270
OAAI
Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDG
2024-10-030
OA
Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes (vol 139, 107624, 2023)
2023-08-011
OAAI
Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes
2023-07-0111
OAAI
Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia
2022-06-167
PRE
Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines
2021-09-2025
OAAI
Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study

新生儿筛查与早期饮食管理对长链3-羟酰CoA脱氢酶缺乏症及中链酰CoA脱氢酶缺乏症患者临床结局的影响——一项全国性回顾性研究

2021-08-244
OAAI
Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?

是否应该对磷酸变位酶2-CDG (PMM2-CDG) 患者进行肾上腺功能不全筛查?

2021-08-017
OAAI